Soluble FMS-Like Tyrosine Kinase-1 Is a Marker of Endothelial Dysfunction During Sepsis

Journal of Clinical Medicine Research
doi 10.14740/jocmr3505w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elmer Press, Inc.

Related search

Soluble FMS-Like Tyrosine Kinase 1 Localization in Renal Biopsies of Chronic Kidney Disease

Kidney International Reports
Nephrology
2019English

Resveratrol Inhibits Release of Soluble FMS-Like Tyrosine Kinase (sFlt-1) and Soluble Endoglin and Improves Vascular Dysfunction – Implications as a Preeclampsia Treatment

Scientific Reports
Multidisciplinary
2017English

Soluble FMS-Like Tyrosine Kinase-1 Alters Cellular Metabolism and Mitochondrial Bioenergetics in Preeclampsia

Frontiers in Physiology
Physiology
2018English

P103: Soluble FMS-like Tyrosine Kinase-1 (sFlt-1) Potential Biomarker for Early Pregnancy Loss Prevention

American Journal of Reproductive Immunology
GynecologyReproductive MedicineImmunologyObstetricsAllergy
2018English

FLT3 (FMS-like Tyrosine Kinase 3)

Atlas of Genetics and Cytogenetics in Oncology and Haematology
Cancer ResearchOncologyGeneticsHematology
2011English

Nitric Oxide Formation Is Inversely Related to Serum Levels of Antiangiogenic Factors Soluble FMS-Like Tyrosine Kinase-1 and Soluble Endogline in Preeclampsia

Hypertension
Internal Medicine
2008English

Sodium Hydrosulfide Prevents Hypertension and Increases in Vascular Endothelial Growth Factor and Soluble FMS-Like Tyrosine Kinase-1 in Hypertensive Pregnant Rats

Naunyn-Schmiedeberg's Archives of Pharmacology
MedicinePharmacology
2016English

The Influence of Overweight and Obesity on Maternal Soluble FMS-Like Tyrosine Kinase 1 and Its Relationship With Leptin During Pregnancy

Reproductive Sciences
GynecologyObstetrics
2012English

Maternal Plasma Soluble FMS-Like Tyrosine Kinase-1 and Free Vascular Endothelial Growth Factor at 11 to 13 Weeks of Gestation in Preeclampsia

Prenatal Diagnosis
GynecologyGeneticsObstetrics
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy